Disease
4 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 12, 2026 · JOURNAL ARTICLE
Human Vaccines & Immunotherapeutics
Expert perspective and strategic framework arguing that measles eradication can serve as a vehicle for strengthening immunization systems and health equity, supported by conceptual reasoning rather than empirical trial data.
AUG 4, 2026 · JOURNAL ARTICLE
Diagnostic Microbiology and Infectious Disease
Diagnostic validation study in an outbreak setting with modest sample size and primarily descriptive molecular findings; detects pathogen DNA but lacks clinical outcome data or comparative diagnostic accuracy metrics.
JUL 10, 2026 · REVIEW/COMPARISON ANALYSIS
Emerging Microbes & Infections
A narrative synthesis of human epidemiological and clinical data on two related viruses to inform vaccine development strategy, without new primary data or comparative efficacy evidence.
JUL 7, 2026 · JOURNAL ARTICLE
Human Vaccines & Immunotherapeutics
A narrative commentary synthesizing existing evidence on mumps vaccine limitations and recommending policy and vaccine development strategies, without presenting primary trial data or new evidence.